Cited by 1,165RNA Research and SplicingAmyotrophic Lateral Sclerosis ResearchRNA regulation and disease

Characterizing the RNA targets and position-dependent splicing regulation by TDP-43

Open access
Tollervey, James R, Curk, Tomaž, Rogelj, Boris, Briese, Michael, Cereda, Matteo, Kayikci, Melis, König, Julian, Hortobágyi, Tibor +8 more·2011·Nature Neuroscience

Abstract

TDP-43 is a predominantly nuclear RNA-binding protein that forms inclusion bodies in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The mRNA targets of TDP-43 in the human brain and its role in RNA processing are largely unknown. Using individual nucleotide-resolution ultraviolet cross-linking and immunoprecipitation (iCLIP), we found that TDP-43 preferentially bound long clusters of UG-rich sequences in vivo. Analysis of RNA binding by TDP-43 in brains from subjects with FTLD revealed that the greatest increases in binding were to the MALAT1 and NEAT1 noncoding RNAs. We also found that binding of TDP-43 to pre-mRNAs influenced alternative splicing in a similar position-dependent manner to Nova proteins. In addition, we identified unusually long clusters of TDP-43 binding at deep intronic positions downstream of silenced exons. A substantial proportion of alternative mRNA isoforms regulated by TDP-43 encode proteins that regulate neuronal development or have been implicated in neurological diseases, highlighting the importance of TDP-43 for the regulation of splicing in the brain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.2778

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Less than a quarter of affected exons are shared between the transgenic and RNA interference-depletion mouse models of TDP43.

    “However, less than a quarter of affected exons are shared between the transgenic and RNA interference-depletion mouse models.”

    From The neurogenetics of alternative splicing (2016) · cites this paper as [174]

  • Both ALS-associated mutations and changes in wild-type TDP43 expression alter a large programme of alternative exons in mutant mice.

    “Both the ALS-associated mutations and the changes in wild-type TDP43 expression alter a large programme of alternative exons in mutant mice170,174,175.”

    From The neurogenetics of alternative splicing (2016) · cites this paper as [174]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., König, J., Hortobágyi, T., Nishimura, A. L., Župunski, V., Patani, R., Chandran, S., Rot, G., Zupan, B., Shaw, C. E., & Ule, J.
Affiliations
  • MRC Laboratory of Molecular Biology (GB)
  • University of Ljubljana (SI)
  • King's College London (GB)
  • University of Cambridge (GB)
Corresponding author
Ule, Jernej
Venue
Nature Neuroscience
Published
2011-02-27
Volume
14
Issue
4
Pages
452-458
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2136949432
Cited by
1,165
References
38
Citations by year
2026: 62 · 2025: 99 · 2024: 74 · 2023: 87 · 2022: 75 · 2021: 92 · 2020: 59 · 2019: 62 · 2018: 88 · 2017: 61 · 2016: 69 · 2015: 66 · 2014: 73 · 2013: 73 · 2012: 79
FWCI
34.71
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
Wellcome Trust (089701, 089701/Z/09/Z)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
TDP-43, alternative splicing, RNA-binding proteins, pre-mRNA, MALAT1, NEAT1, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, iCLIP, neuronal development, RNA processing
MeSH terms
Brain Chemistry, Cell Line, DNA-Binding Proteins, Gene Expression Regulation, Humans, RNA Splicing, RNA, Messenger, RNA-Binding Proteins, Alternative Splicing, Protein Isoforms, RNA, Untranslated, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review